ApoC-III Polyclonal Antibody

Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase; it is thought to delay catabolism of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia.

The ApoC-III Polyclonal Antibody is a highly specific and reliable tool designed for the detection and quantification of Apolipoprotein C-III (ApoC-III) in various biological samples. This antibody is produced through a rigorous process, ensuring its exceptional quality and performance.

ApoC-III is a key regulator of lipid metabolism and has been implicated in the development of cardiovascular diseases, such as hypertriglyceridemia. The ApoC-III Polyclonal Antibody recognizes and binds to ApoC-III with high affinity, enabling accurate measurement of its expression levels in experimental settings.

This antibody exhibits excellent sensitivity and specificity, making it an ideal choice for a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA). Its versatility allows researchers to investigate the role of ApoC-III in various physiological and pathological processes.

The ApoC-III Polyclonal Antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to ensure batch-to-batch consistency and reproducibility. It is supplied as a liquid formulation, ready for immediate use, eliminating the need for time-consuming reconstitution steps.

With its exceptional performance characteristics and reliable results, the ApoC-III Polyclonal Antibody is an indispensable tool for researchers studying lipid metabolism, cardiovascular diseases, and related fields. Trust in its precision and accuracy to advance your scientific investigations and contribute to the understanding of ApoC-III's role in health and disease.